Navidea Biopharmaceuticals Gross profit (Q1, 2018)276.1 K

Navidea Biopharmaceuticals Gross profit margin (Q1, 2018), %99.9%

Navidea Biopharmaceuticals Net income (Q1, 2018)-6.7 M

Navidea Biopharmaceuticals EBIT (Q1, 2018)-2.5 M

Navidea Biopharmaceuticals Cash, 31-Mar-2018817 K

Navidea Biopharmaceuticals EV41.4 M

USD | FY, 2016 | FY, 2017 |
---|---|---|

## Revenue | 22 m | 1.8 m |

## Cost of goods sold | 2.3 m | 3.7 k |

## Gross profit | 19.7 m | 1.8 m |

| 90% | 100% |

## R&D expense | 8.9 m | 4.5 m |

## General and administrative expense | 13 m | 11.2 m |

## Operating expense total | 21.9 m | 15.7 m |

## EBIT | (2.2 m) | (13.9 m) |

| (10%) | (767%) |

## Interest expense | 14.9 m | 169 k |

## Interest income | 169 k | |

## Pre tax profit | (14.3 m) | (17.8 m) |

## Income tax expense | 4.1 m | |

## Net Income | (14.3 m) | 74.9 m |

USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q1, 2018 |
---|---|---|---|---|---|---|---|---|---|---|

## Revenue | 1.1 m | 2.3 m | 2.1 m | 2.9 m | 4 m | 4.7 m | 5.4 m | 8.5 m | 580 k | 276.4 k |

## Cost of goods sold | 270.5 k | 807.9 k | 449.1 k | 332.7 k | 457.6 k | 534.9 k | 560.7 k | 921.8 k | 318 | |

## Gross profit | 804.2 k | 1.4 m | 1.7 m | 2.5 m | 3.5 m | 4.2 m | 4.8 m | 7.6 m | 580 k | 276.1 k |

| 75% | 64% | 79% | 88% | 89% | 89% | 90% | 89% | 100% | 100% |

## R&D expense | 5.1 m | 4.2 m | 4 m | 2.3 m | 3.9 m | 2.7 m | 2.5 m | 1.3 m | 705.3 k | 999 k |

## General and administrative expense | 4.9 m | 2.6 m | 5.5 m | 4 m | 3.9 m | 4.1 m | 2.9 m | 2.9 m | 3 m | 1.8 m |

## Operating expense total | 10 m | 6.8 m | 9.5 m | 6.3 m | 7.8 m | 6.8 m | 5.4 m | 4.2 m | 3.7 m | 2.8 m |

## EBIT | (9.2 m) | (5.4 m) | (7.8 m) | (3.8 m) | (4.3 m) | (2.6 m) | (580 k) | 3.4 m | (3.1 m) | (2.5 m) |

| (858%) | (238%) | (371%) | (133%) | (109%) | (54%) | (11%) | 40% | (543%) | (904%) |

## Interest expense | 914.1 k | 920.9 k | 966.6 k | 1.6 m | 2.1 m | 2.2 m | 7.5 m | 2.6 m | ||

## Interest income | 5 k | 2.9 k | 31.4 k | |||||||

## Pre tax profit | (4.3 m) | (6.7 m) | ||||||||

## Net Income | (22 m) | (28.9 m) | (7.3 m) | (17 m) | (25.1 m) | (3.7 m) | (10.4 m) | (10.4 m) | 85.6 m | (6.7 m) |

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|

## Cash | 32.9 m | 5.5 m | 7.2 m | 1.5 m | 2.8 m |

## Accounts Receivable | 1.2 m | 816.5 k | |||

## Inventories | 2.2 m | 1.5 m | |||

## Current Assets | 37.3 m | 8.6 m | 12.6 m | 10.8 m | 13.8 m |

## PP&E | 2.1 m | 2.5 m | 1.9 m | 1.3 m | 236.7 k |

## Total Assets | 40.3 m | 11.9 m | 15 m | 12.5 m | 20.8 m |

## Accounts Payable | 2.4 m | 1.5 m | 1.8 m | 7.1 m | 855 k |

## Short-term debt | |||||

## Current Liabilities | 11.3 m | 9.1 m | 6.2 m | 69.9 m | 8.1 m |

## Long-term debt | |||||

## Total Liabilities | 80.1 m | 8.7 m | |||

## Additional Paid-in Capital | 313.1 m | 323 m | 326.1 m | 326.6 m | 331.1 m |

## Retained Earnings | (317.3 m) | (353 m) | (380.5 m) | (394.9 m) | (319.9 m) |

## Total Equity | 12 m | ||||

## Financial Leverage | 1.7 x |

USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q1, 2018 |
---|---|---|---|---|---|---|---|---|---|---|

## Cash | 17.5 m | 10.4 m | 4.9 m | 15.8 m | 11.4 m | 5.5 m | 1.2 m | 810.4 k | 13.4 m | 817 k |

## Accounts Receivable | 487.1 k | 1.5 m | 1.2 m | 1.8 m | 1.9 m | |||||

## Inventories | 1.9 m | 1.1 m | 571.6 k | 1.2 m | 877.2 k | 898.9 k | 769.8 k | 804.9 k | 748 | |

## Current Assets | 20.6 m | 14 m | 8 m | 19.5 m | 15 m | 10 m | 6.9 m | 9.4 m | 21.7 m | 16.2 m |

## PP&E | 2.8 m | 2.6 m | 2.3 m | 2.2 m | 2.1 m | 1.8 m | 1.6 m | 1.4 m | 1.1 m | 206.1 k |

## Total Assets | 23.6 m | 17.6 m | 10.9 m | 22.2 m | 17.5 m | 12.3 m | 8.7 m | 11.2 m | 32.9 m | 18.3 m |

## Accounts Payable | 1.7 m | 2.4 m | 1.9 m | 1.4 m | 1.3 m | 2.9 m | 5.1 m | 4.9 m | 3.1 m | 700.2 k |

## Short-term debt | 2.3 m | |||||||||

## Current Liabilities | 6.2 m | 8.3 m | 12.9 m | 5.6 m | 6.2 m | 57.1 m | 62.4 m | 63.8 m | 10 m | 12 m |

## Long-term debt | 2.3 m | |||||||||

## Total Debt | 4.6 m | |||||||||

## Total Liabilities | 13.4 m | |||||||||

## Additional Paid-in Capital | 315.2 m | 314.7 m | 324.3 m | 324.7 m | 325.6 m | 326.4 m | 326.4 m | 326.6 m | 330.8 m | 331.5 m |

## Retained Earnings | (339.2 m) | (346.1 m) | (360.3 m) | (370 m) | (378 m) | (384.2 m) | (390.9 m) | (391 m) | (309.3 m) | (327.3 m) |

## Total Equity | 22.4 m | 4.9 m | ||||||||

## Financial Leverage | 1.5 x | 3.7 x |

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|

## Net Income | (42.7 m) | (35.7 m) | (27.6 m) | (14.3 m) | 74.9 m |

## Accounts Receivable | (1 m) | 334.1 k | |||

## Inventories | (1.9 m) | 761 k | 136 k | (861.3 k) | 1.5 m |

## Accounts Payable | 1 m | (944.9 k) | 290 k | 5.4 m | (6 m) |

## Cash From Operating Activities | (35.6 m) | (29.1 m) | (19.1 m) | 3.6 m | 59.1 m |

## Cash From Investing Activities | (1.3 m) | (1.5 m) | (27.8 k) | (39.2 k) | (1.8 m) |

## Short-term Borrowings | (6 m) | (25 m) | (30.3 m) | (231.5 k) | |

## Long-term Borrowings | (59.8 m) | ||||

## Dividends Paid | |||||

## Cash From Financing Activities | 60.7 m | 3.2 m | 20.8 m | (9.1 m) | (56 m) |

USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q1, 2018 |
---|---|---|---|---|---|---|---|---|---|---|

## Net Income | (22 m) | (28.9 m) | (7.3 m) | (17 m) | (25.1 m) | (3.7 m) | (10.4 m) | (10.4 m) | 85.6 m | (6.7 m) |

## Depreciation and Amortization | 235.4 k | 360.7 k | 149.8 k | 299.1 k | 431.4 k | 149.6 k | 267.4 k | 378.8 k | 86.5 k | 38 k |

## Accounts Receivable | 663.5 k | (314.8 k) | (394.5 k) | (1 m) | (1.1 m) | 903.1 k | 181.8 k | 210.5 k | ||

## Inventories | 326.7 k | 573.2 k | 240.5 k | (355.5 k) | (83.7 k) | (246 k) | (116.9 k) | (195.3 k) | 1.5 m | |

## Accounts Payable | (748.3 k) | (45.4 k) | 428.5 k | (119.8 k) | (178.6 k) | 1.1 m | 3.4 m | 3.2 m | (3.8 m) | (154.8 k) |

## Cash From Operating Activities | (17.6 m) | (24.3 m) | (4.1 m) | (10.8 m) | (14.9 m) | (1.7 m) | (1.4 m) | 1.3 m | 66.3 m | (2.3 m) |

## Cash From Investing Activities | (1.1 m) | (1.5 m) | 14.7 k | (17.3 k) | (19.2 k) | (1.8 k) | (39.2 k) | (39.2 k) | 400 k | |

## Short-term Borrowings | (25 m) | (25 m) | (30 m) | (30.3 m) | (189.2 k) | (189.2 k) | (59.5 m) | |||

## Long-term Borrowings | (118.3 k) | |||||||||

## Cash From Financing Activities | 3.2 m | 3.2 m | 3.5 m | 21.1 m | 20.8 m | (693 ) | (4.6 m) | (7.6 m) | (54.4 m) | (118.1 k) |

USD | Y, 2018 |
---|---|

## EV/EBIT | -16.6 x |

## EV/CFO | -18.3 x |

## Revenue/Employee | 12.6 k |

## Financial Leverage | 3.7 x |

Report incorrect company information